288 related articles for article (PubMed ID: 6245712)
1. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.
Lips JP; Sixma JJ; Schiphorst ME
Biochim Biophys Acta; 1980 Apr; 628(4):451-67. PubMed ID: 6245712
[TBL] [Abstract][Full Text] [Related]
2. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
3. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
Legrand C; Dubernard V; Caen J
Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
[TBL] [Abstract][Full Text] [Related]
4. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
Lam SC; Guccione MA; Packham MA; Mustard JF
Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
[TBL] [Abstract][Full Text] [Related]
5. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
6. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
[TBL] [Abstract][Full Text] [Related]
7. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.
Bishop GA; Rozenberg MC
Biochim Biophys Acta; 1975 Mar; 384(1):112-9. PubMed ID: 165830
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of phospholipase D in rabbit platelet membranes by nucleoside triphosphates and by phosphocreatine: roles of membrane-bound GDP, nucleoside diphosphate kinase and creatine kinase.
Fan XT; Sherwood JL; Haslam RJ
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):701-9. PubMed ID: 8192658
[TBL] [Abstract][Full Text] [Related]
9. Interaction of adenosine and adenylnucleotides with the human platelet membrane. Further characterization of the ADP binding sites.
Bauvois B; Legrand C; Caen JP
Haemostasis; 1980; 9(2):92-104. PubMed ID: 7358322
[TBL] [Abstract][Full Text] [Related]
10. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
Plow EF; Marguerie GA
J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
[TBL] [Abstract][Full Text] [Related]
11. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of an ADP receptor mediating platelet activation.
Colman RW; Figures WR
Mol Cell Biochem; 1984; 59(1-2):101-11. PubMed ID: 6323960
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 .
Boullin DJ; Green AR; Price KS
J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984
[TBL] [Abstract][Full Text] [Related]
14. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 3'-O-(1-naphthoyl)adenosine 5'-diphosphate, a fluorescent adenosine 5'-diphosphate analogue, with the adenosine 5'-diphosphate/adenosine 5'-triphosphate carrier protein in the mitochondrial membrane.
Block MR; Lauquin GJ; Vignais PV
Biochemistry; 1982 Oct; 21(22):5451-7. PubMed ID: 7171567
[TBL] [Abstract][Full Text] [Related]
16. Binding of adenosine diphosphate to intact human platelets.
Born GV; Feinberg H
J Physiol; 1975 Oct; 251(3):803-16. PubMed ID: 1185683
[TBL] [Abstract][Full Text] [Related]
17. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues.
Jefferson JR; Harmon JT; Jamieson GA
Blood; 1988 Jan; 71(1):110-6. PubMed ID: 3334892
[TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
